On September 7, 2018, the "2018 Academic Conference of the Traditional Oncology Medicine Committee of the China Anti-Cancer Association" sponsored by the Cancer Traditional Medicine Professional Committee of the China Anti-Cancer Association and co-organized by the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine and Henan Provincial Cancer Hospital was successfully concluded in Zhengzhou, Henan Province. The conference was unprecedented, gathering top experts in the field of oncology at home and abroad such as Germany, Beijing, Tianjin, Shanghai, Zhejiang, Anhui, Shanxi, Hunan, Jilin, etc., with more than 450 participants and in-depth reports from many media. During the meeting, Mengyang Pharmaceutical's

At the opening ceremony of the conference, Professor Liu Changxiao, Dean of the School of Traditional Chinese Medicine of Tianjin University of Traditional Chinese Medicine and Academician of the Chinese Academy of Engineering, Lin Hongsheng, Chairman of the International Alliance of Traditional Chinese Medicine Oncology, Zhang Jianfeng, Deputy Director of Henan Provincial Administration of Traditional Chinese Medicine, Wang Duanquan, Secretary-General of Henan Association of Traditional Chinese Medicine, Luo Suxia, Vice President of Henan Provincial Cancer Hospital, Jia Yingjie, Director of the Oncology Department of the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, and Liu Huaimin, Director of the Diagnosis and Treatment Center of Integrated Traditional Chinese and Western Medicine of Henan Provincial Cancer Hospital, delivered speeches respectively. The meeting was presided over by Professor Li Xiaojiang, Secretary General of the Traditional Oncology Committee of the Chinese Anti-Cancer Association and Deputy Director of the Department of Oncology of the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine.

The conference deeply discussed the strategy, application, current situation and thinking of traditional Chinese medicine and integrated Chinese and Western medicine in the treatment of malignant tumors, which more effectively promoted the development of traditional medicine in the treatment of malignant tumors, better served the majority of patient groups, and played a strong role in promoting "Healthy China".

During the meeting, Hubei Mengyang Pharmaceutical Co., Ltd. held a satellite meeting on "Combining Chinese and Western Foods to Better Care for Patients". Chaired by Professor Lin Hongsheng and Professor Jia Yingjie, Ms. Zhou Huiying, deputy general manager of the company, delivered a speech, and Professor Shao Mengyang, a famous oncologist in China and the inventor of Shengbai oral liquid (mixture) product, attended the meeting and accepted the flowers presented by representatives of enterprises and doctors.

Representatives of enterprises and doctors presented flowers to Mr. Shao

Dr. Liu Shuo from Guang'anmen Hospital, China Academy of Chinese Medical Sciences, made an invited report on the progress of clinical application of Shengbai Oral Liquid (Mixture), the latest developments and future development trends of TCM Oncology at the satellite meeting, highlighting the advantages, characteristics and status of Shengbai Oral Liquid (Mixture) in the prevention and treatment of myelosuppression after chemotherapy and radiotherapy, and strengthening the academic discussion on new concepts, methods, and progress in tumor diagnosis, prevention and treatment. The atmosphere of the conference was warm and the academic atmosphere was strong.

Professor Jia Yingjie, Chairman of the Society and Director of the Department of Oncology of the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, pointed out that the conference was a high-level, high-level and high-quality international oncology event, with the theme of "Co-construction and Sharing, Promoting the Sustainable Development of Traditional Oncology Medicine". Through the convening of this conference, it has built a platform for colleagues engaged in oncology in China to communicate with each other, Xi learn from each other, learn from each other, learn from each other, and display their achievements, and at the same time, it also provides an opportunity for colleagues to conduct academic exchanges with their domestic counterparts.

The meeting members took a group photo